Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support.

0 CARDIAC & CARDIOVASCULAR SYSTEMS Interdisciplinary cardiovascular and thoracic surgery Pub Date : 2024-06-05 DOI:10.1093/icvts/ivae091
Takayuki Gyoten, Eisuke Amiya, Akihito Saito, Minoru Ono
{"title":"Predictors of long-term success after successful explantation of continuous flow left ventricular assist device support.","authors":"Takayuki Gyoten, Eisuke Amiya, Akihito Saito, Minoru Ono","doi":"10.1093/icvts/ivae091","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Predictors and evaluations of continuous flow left ventricular assist device (cf-LVAD) explantation in recovered patients remain under discussion due to lack of evidence on long-term safety and efficacy. This study summarized our experiences regarding cf-LVAD explantation in non-ischaemic dilated cardiomyopathy patients and estimated a predictor for sufficient myocardial recovery allowing left ventricular assist device explant.</p><p><strong>Methods: </strong>We retrospectively identified 135 adult patients with cf-LVAD therapy as bridge to heart transplant due to non-ischaemic dilated cardiomyopathy. Of those, 13 patients underwent device explantation (recovery group) after myocardial recovery. Twelve (92%) of the explanted patients were evaluated using our weaning protocol and underwent surgical explantation. Meanwhile, the remaining 122 continued with cf-LVAD therapy (non-recovery group).</p><p><strong>Results: </strong>Multivariate logistic regression analysis revealed time interval between the first heart failure event and cf-LVAD implantation as an independent predictor for successful explantation. The optimal time interval cutoff value to predict cf-LVAD explantation was 7 months, with a sensitivity of 91.0% and specificity of 84.6%. Echocardiography in patients with successful cf-LVAD explantation showed significant improvement of left ventricular function and dimensions at 6 months postoperatively. The 13 explanted patients are currently alive at a median of 30 (interquartile range; 18-58) months after explantation. The survival rate free from rehospitalization due to heart failure following explantation was 100%. Left ventricular function and remodelling after explantation were also preserved.</p><p><strong>Conclusions: </strong>In non-ischaemic dilated cardiomyopathy patients with a short interval between the first heart failure event and cf-LVAD therapy, left ventricular myocardium may recover in an early phase after device implantation.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11878525/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Predictors and evaluations of continuous flow left ventricular assist device (cf-LVAD) explantation in recovered patients remain under discussion due to lack of evidence on long-term safety and efficacy. This study summarized our experiences regarding cf-LVAD explantation in non-ischaemic dilated cardiomyopathy patients and estimated a predictor for sufficient myocardial recovery allowing left ventricular assist device explant.

Methods: We retrospectively identified 135 adult patients with cf-LVAD therapy as bridge to heart transplant due to non-ischaemic dilated cardiomyopathy. Of those, 13 patients underwent device explantation (recovery group) after myocardial recovery. Twelve (92%) of the explanted patients were evaluated using our weaning protocol and underwent surgical explantation. Meanwhile, the remaining 122 continued with cf-LVAD therapy (non-recovery group).

Results: Multivariate logistic regression analysis revealed time interval between the first heart failure event and cf-LVAD implantation as an independent predictor for successful explantation. The optimal time interval cutoff value to predict cf-LVAD explantation was 7 months, with a sensitivity of 91.0% and specificity of 84.6%. Echocardiography in patients with successful cf-LVAD explantation showed significant improvement of left ventricular function and dimensions at 6 months postoperatively. The 13 explanted patients are currently alive at a median of 30 (interquartile range; 18-58) months after explantation. The survival rate free from rehospitalization due to heart failure following explantation was 100%. Left ventricular function and remodelling after explantation were also preserved.

Conclusions: In non-ischaemic dilated cardiomyopathy patients with a short interval between the first heart failure event and cf-LVAD therapy, left ventricular myocardium may recover in an early phase after device implantation.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
持续流左心室辅助装置支持成功拆卸后长期成功的预测因素。
目的:由于缺乏有关长期安全性和有效性的证据,对康复患者更换连续流左心室辅助装置(cf-LVAD)的预测和评估仍在讨论之中。本研究总结了我们在非缺血性扩张型心肌病患者中进行 cf-LVAD 移植的经验,并估算了心肌充分恢复允许 LVAD 移植的预测指标:我们回顾性地发现了135名因非缺血性扩张型心肌病而接受cf-LVAD治疗作为心脏移植桥梁的成年患者。其中,13 名患者在心肌恢复后进行了装置拆卸(恢复组)。其中 12 名(92%)被拆除装置的患者根据我们的断流方案进行了评估,并接受了手术拆除。与此同时,其余122名患者继续接受cf-LVAD治疗(非恢复组):结果:多变量逻辑回归分析显示,首次心衰事件与 cf-LVAD 植入之间的时间间隔是成功移植的独立预测因素。预测 cf-LVAD 移植成功的最佳时间间隔临界值为 7 个月,敏感性为 91.0%,特异性为 84.6%。成功进行 cf-LVAD 移植的患者的超声心动图显示,术后 6 个月左心室功能和尺寸明显改善。目前,13 名被置换的患者在置换后的中位生存期为 30 个月(IQR; 18-58 个月)。移植后未因心力衰竭再次住院的存活率为 100%。移植后的左心室功能和重塑也得到了保留:结论:非缺血性扩张型心肌病患者在首次发生心衰和接受 cf-LVAD 治疗之间的间隔时间较短,植入装置后左心室心肌可在早期恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A case of sinus of Valsalva aneurysm associated with a single coronary artery successfully treated by Bentall surgery. Simultaneous ligation of vessels during robotic right upper lobectomy. Clamp On vs Off. Impact of distal anastomotic technique during ascending aortic replacement in acute type A aortic dissection: IRAD insights. Efficacy of Non-Powered Stapler in Lung Volume Reduction Surgery of Severe Lung Emphysema: A Prospective Randomized Single-Blinded Monocentric Study. Refitting EuroSCORE II for 120-Day Mortality After Coronary Artery Bypass Grafting Using Nationwide Registry Data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1